Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2026-03-02 @ 7:44 AM
Study NCT ID:
NCT06284850
Status:
RECRUITING
Last Update Posted:
2024-02-29
First Post:
2024-01-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Empagliflozin and Red Blood Cell 2,3-biphosphoglycerate Levels
Sponsor:
Aristotle University Of Thessaloniki
Organization: